Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 107 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA178748
National Institutes of Health
Grant: U54-CA151652
NCI NIH HHS
Grant: P30 CA016086
NCI NIH HHS
Grant: U54 CA198999
NCI NIH HHS
Grant: U54 CA151652
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01LM013039-02
HealthyMe/MiSalud Smartphone Application: Identifying Mechanisms to Engage African Americans and Hispanics in Personal Health Libraries
National Institutes of Health
Grant: 5R01CA178748-03
Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy
National Institutes of Health
Grant: 1U54CA151652-01
Developmental Projects and Trans-Alliance Activities
FWCI
4.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
Additional file 1 of Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
Additional file 1 of MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers
Additional file 1 of MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers